Abstract
In the present study, the predictive value of ionising radiation (IR)-induced cell death was tested in peripheral blood lymphocytes (PBLs) and their corresponding Epstein-Barr virus-transformed lymphoblastoid cell lines (LCLs) in an interlaboratory comparison. PBLs and their corresponding LCLs were derived from 15 tumour patients, that were considered clinically radiosensitive based on acute side-effects, and matched controls. Upon coding of the samples, radiosensitivity of the matched pairs was analysed in parallel in three different laboratories by assessing radiation-induced apoptotic and necrotic cell death using annexin V. All participating laboratories detected a dose-dependent increase of apoptosis and necrosis in the individual samples, to a very similar extent. However, comparing the mean values of apoptotic and necrotic levels derived from PBLs of the radiosensitive cohort with the mean values of the control cohort did not reveal a significant difference. Furthermore, within 15 matched pairs, no sample was unambiguously and independently identified by all three participating laboratories to demonstrate in vitro hypersensitivity that matched the clinical hypersensitivity. As has been reported previously, apoptotic and necrotic cell death is barely detectable in immortalised LCL derivatives using low doses of IR. Concomitantly, the differences in apoptosis or necrosis levels found in primary cells of different individuals were not observed in the corresponding LCL derivatives. All participating laboratories concordantly reasoned that, with the methods applied here, IR-induced cell death in PBLs is unsuitable to unequivocally predict the individual clinical radiosensitivity of cancer patients. Furthermore, LCLs do not reflect the physiological properties of the corresponding primary blood lymphocytes with regard to IR-induced cell death. Their value to predict clinical radiosensitivity is thus highly questionable.
Similar content being viewed by others
References
Working group (1995) LENT SOMA scales for all anatomic sites. Int J Radiat Oncol Biol Phys 31:1049–1091. doi:10.1016/0360-3016(95)90159-0
Alter BP (2002) Radiosensitivity in Fanconi’s anemia patients. Radiother Oncol 62:345–347. doi:10.1016/S0167-8140(01)00474-1
Andreassen CN, Alsner J, Overgaard J (2002) Does variability in normal tissue reactions after radiotherapy have a genetic basis—where and how to look for it? Radiother Oncol 64:131–140. doi:10.1016/S0167-8140(02)00154-8
Archambeau JO, Pezner R, Wasserman T (1995) Pathophysiology of irradiated skin and breast. Int J Radiat Oncol Biol Phys 31:1171–1185. doi:10.1016/0360-3016(94)00423-I
Baumann M (1995) Impact of endogenous and exogenous factors on radiation sequelae. In: Dunst J, Suaer R (eds) Hrsg: late sequelae in oncology. medical radiology, diagnostic imaging and radiation oncology. Springer, Berlin
Bland JM, Altman DG (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1:307–310
Borgmann K, Hoeller U, Nowack S et al (2008) Individual radiosensitivity measured with lymphocytes may predict the risk of acute reaction after radiotherapy. Int J Radiat Oncol Biol Phys 71:256–264. doi:10.1016/j.ijrobp.2008.01.007
Cohen JI (2000) Epstein-Barr virus infection. N Engl J Med 343:481–492. doi:10.1056/NEJM200008173430707
Connor J, Bucana C, Fidler IJ et al (1989) Differentiation-dependent expression of phosphatidylserine in mammalian plasma membranes: quantitative assessment of outer-leaflet lipid by prothrombinase complex formation. Proc Natl Acad Sci USA 86:3184–3188. doi:10.1073/pnas.86.9.3184
Cooper JS, Fu K, Marks J et al (1995) Late effects of radiation therapy in the head and neck region. Int J Radiat Oncol Biol Phys 31:1141–1164. doi:10.1016/0360-3016(94)00421-G
Cox JD, Stetz J, Pajak TF (1995) Toxicity criteria of the radiation therapy oncology group (RTOG) and the european organization for research and treatment of cancer (EORTC). Int J Radiat Oncol Biol Phys 31:1341–1346. doi:10.1016/0360-3016(95)00060-C
Dikomey E, Borgmann K, Brammer I et al (2003) Molecular mechanisms of individual radiosensitivity studied in normal diploid human fibroblasts. Toxicology 193:125–135. doi:10.1016/S0300-483X(03)00293-2
Dikomey E, Borgmann K, Peacock J et al (2003) Why recent studies relating normal tissue response to individual radiosensitivity might have failed and how new studies should be performed. Int J Radiat Oncol Biol Phys 56:1194–1200. doi:10.1016/S0360-3016(03)00188-3
Henderson S, Huen D, Rowe M et al (1993) Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc Natl Acad Sci USA 90:8479–8483. doi:10.1073/pnas.90.18.8479
Henery S, George T, Hall B et al (2008) Quantitative image based apoptotic index measurement using multispectral imaging flow cytometry: a comparison with standard photometric methods. Apoptosis 13:1054–1063. doi:10.1007/s10495-008-0227-4
Huber R, Braselmann H, Bauchinger M (1989) Screening for interindividual differences in radiosensitivity by means of the micronucleus assay in human lymphocytes. Radiat Environ Biophys 28:113–120. doi:10.1007/BF01210295
Konemann S, Bolling T, Kolkmeyer A et al (2005) Heterogeneity of radiation induced apoptosis in Ewing tumor cell lines characterized on a single cell level. Apoptosis 10:177–184. doi:10.1007/s10495-005-6072-9
Lee JM, Lee KH, Farrell CJ et al (2004) EBNA2 is required for protection of latently Epstein-Barr virus-infected B cells against specific apoptotic stimuli. J Virol 78:12694–12697. doi:10.1128/JVI.78.22.12694-12697.2004
MacKay RI, Niemierko A, Goitein M et al (1998) Potential clinical impact of normal-tissue intrinsic radiosensitivity testing. Radiother Oncol 46:215–216. doi:10.1016/S0167-8140(97)00179-5
Meijer AE, Zhivotovsky B, Lewensohn R (1999) Epstein-Barr virus-transformed lymphoblastoid cell lines of ataxia telangiectasia patients are defective in X-ray-induced apoptosis. Int J Radiat Biol 75:709–716. doi:10.1080/095530099140041
Neitzel H (1986) A routine method for the establishment of permanent growing lymphoblastoid cell lines. Hum Genet 73:320–326. doi:10.1007/BF00279094
Okada M, Goto M, Furuichi Y et al (1998) Differential effects of cytotoxic drugs on mortal and immortalized B-lymphoblastoid cell lines from normal and Werner’s syndrome patients. Biol Pharm Bull 21:235–239
Okubo M, Tsurukubo Y, Higaki T et al (2001) Clonal chromosomal aberrations accompanied by strong telomerase activity in immortalization of human B-lymphoblastoid cell lines transformed by Epstein-Barr virus. Cancer Genet Cytogenet 129:30–34. doi:10.1016/S0165-4608(01)00420-4
Pavy JJ, Denekamp J, Letschert J et al (1995) EORTC late effects working group. Late effects toxicity scoring: the SOMA scale. Radiother Oncol 35:11–15. doi:10.1016/0167-8140(95)97448-M
Riesenbeck D, Dorr W (1998) Documentation of radiation-induced oral mucositis. scoring systems. Strahlenther Onkol 174(Suppl 3):44–46
Riesenbeck D, Dorr W, Feyerabend T et al (1998) Photographic documentation of acute radiation-induced side effects of the oral mucosa. Strahlenther Onkol 174(Suppl 3):40–43
Rubin P, Constine LSIII, Fajardo LF et al (1995) EORTC late effects working group. Overview of late effects normal tissues (LENT) scoring system. Radiother Oncol 35:9–10. doi:10.1016/0167-8140(95)97447-L
Sagan D, Mortl S, Muller I et al (2007) Enhanced CD95-mediated apoptosis contributes to radiation hypersensitivity of NBS lymphoblasts. Apoptosis 12:753–767. doi:10.1007/s10495-006-0021-0
Satoh M, Yasuda T, Higaki T et al (2003) Innate apoptosis of human B lymphoblasts transformed by Epstein-Barr virus: modulation by cellular immortalization and senescence. Cell Struct Funct 28:61–70. doi:10.1247/csf.28.61
Schmitz A, Bayer J, Dechamps N et al (2007) Heritability of susceptibility to ionizing radiation-induced apoptosis of human lymphocyte subpopulations. Int J Radiat Oncol Biol Phys 68:1169–1177. doi:10.1016/j.ijrobp.2007.03.050
Schmitz A, Bayer J, Dechamps N et al (2003) Intrinsic susceptibility to radiation-induced apoptosis of human lymphocyte subpopulations. Int J Radiat Oncol Biol Phys 57:769–778. doi:10.1016/S0360-3016(03)00637-0
Severin E, Greve B, Pascher E et al (2006) Evidence for predictive validity of blood assays to evaluate individual radiosensitivity. Int J Radiat Oncol Biol Phys 64:242–250. doi:10.1016/j.ijrobp.2005.06.020
Shi YQ, Li L, Sanal O et al (2001) High levels of delayed radiation-induced apoptosis observed in lymphoblastoid cell lines from ataxia-telangiectasia patients. Int J Radiat Oncol Biol Phys 49:555–559. doi:10.1016/S0360-3016(00)01478-4
Sugimoto M, Tahara H, Ide T et al (2004) Steps involved in immortalization and tumorigenesis in human B-lymphoblastoid cell lines transformed by Epstein-Barr virus. Cancer Res 64:3361–3364. doi:10.1158/0008-5472.CAN-04-0079
Takahashi T, Kawabe T, Okazaki Y et al (2003) In vitro establishment of tumorigenic human B-lymphoblastoid cell lines transformed by Epstein-Barr virus. DNA Cell Biol 22:727–735. doi:10.1089/104454903770946700
Utsugi T, Schroit AJ, Connor J et al (1991) Elevated expression of phosphatidylserine in the outer membrane leaflet of human tumor cells and recognition by activated human blood monocytes. Cancer Res 51:3062–3066
Zimmermann JS, Kumpf L, Kimmig B (1998) Variability of individual normal tissue radiation sensitivity. an international empirical evaluation of endogenous and exogenous response modifiers. Strahlenther Onkol 174(Suppl 3):16–19
Zou P, Kawada J, Pesnicak L et al (2007) Bortezomib induces apoptosis of Epstein-Barr virus (EBV)-transformed B cells and prolongs survival of mice inoculated with EBV-transformed B cells. J Virol 81:10029–10036. doi:10.1128/JVI.02241-06
Acknowledgments
The authors would like to thank Annette van Dülmen and Gerlind Bellmann for excellent technical assistance. The project was financed by the Federal Office for Radiation Protection (“Bundesamt für Strahlenschutz”), Department of Radiation Protection and Health, Oberschleissheim, Germany (StSch 4467).
Authors’ Contribution and Conflict of Interest
The authors declare that they all participated in the study and that they have seen and approved the final version. They declare no conflict of interest or financial relationship influencing the conclusions of the work.
Author information
Authors and Affiliations
Corresponding author
Additional information
The authors B. Greve, K. Dreffke and A. Rickinger are treated as first authors.
Rights and permissions
About this article
Cite this article
Greve, B., Dreffke, K., Rickinger, A. et al. Multicentric investigation of ionising radiation-induced cell death as a predictive parameter of individual radiosensitivity. Apoptosis 14, 226–235 (2009). https://doi.org/10.1007/s10495-008-0294-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10495-008-0294-6